Startups
The opioid epidemic is just that—an epidemic. To date, there are no technologies or treatment plans that successfully act as preventative measures against opioid addiction and overdose. We intend to change that.
Overview
Location
United States
Employees
51-200
Total raised
$23M
Founded date
2015
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 1, 2017 | Term Sheet — Wednesday, March 1 | EXITING THE EXIT Good morning, Term Sheet readers. Laura Entis here, filling in for Erin while she’s on vacation. (Please continue to email me any deal listings: [email protected]) Paid Content Securing the enterprise without boundari... |
| Mar 1, 2017 | Muse Bio Secures $23M Series B financing | BOULDER, CO, Privately-held company leading the development of next-generation genome engineering capabilities, today announced the completion of a $23 million Series B financing. >> Click here for more funding data on Muse Bio &g... |
| Mar 1, 2017 | Venrock Leads $23M Series B for Muse Bio | Muse bio, a privately-held company leading the development of next-generation genome engineering capabilities, today announced the completion of a $23 million Series B financing. The oversubscribed financing was led by Venrock and included ... |
| Feb 28, 2017 | Muse bio Completes $23m Series B Financing | Muse bio, a Boulder, CO-based developer of genome engineering capabilities, completed a $23m Series B financing. The round was led by Venrock with participation from Foresite Capital and Paladin Capital as well as existing investors NanoDim... |
Reviews 0
FAQ about Muse Bio
When was Muse Bio founded?
Muse Bio was founded in 2015.
How much funding has Muse Bio raised?
Muse Bio has raised $23M in total across 1 funding round.
What has the press written about Muse Bio?
Parsers VC has collected 5 articles mentioning Muse Bio, among them “Term Sheet — Wednesday, March 1” (Mar 1, 2017) and “Muse Bio Secures $23M Series B financing” (Mar 1, 2017).
Is Muse Bio still active?
Muse Bio is probably closed: its latest activity on Parsers VC dates from Mar 1, 2017.